However, mutant KRAS significantly affected the expression of a greater number of mRNAs in colon cancer cells and was still more redundant with c-Myc than the other way around (Fig. 6A, B), suggesting that the mechanism is more complex than the simple domination of a broader expression regulator. Here, KRAS is linked to colonic neoplasm.